Tools chosen: kalshi_direct claude_news gdelt_news wikipedia kalshi_related polymarket_related

Sub-questions (Fermi decomposition)

Planner reasoning

This is a global health question about wild poliovirus type 1 (WPV1) elimination, with a market resolving Yes if any year 2024-2029 records zero wild polio cases. Key drivers are current case counts, the trend in endemic countries (Pakistan, Afghanistan), and expert/GPEI timelines. I anchor on the Kalshi price, then research recent WPV1 case data and eradication projections.

# Current state Wild poliovirus type 1 (WPV1) remains endemic in Pakistan and Afghanistan. Resolution requires zero reported WPV1 cases in any single calendar year between 2024–2029. As of mid-2026, both countries continue reporting cases, with no year yet reaching zero. # Timeline of key events - **2023**: Low WPV1 case count (baseline; ~6 cases Pakistan, ~6 Afghanistan — implied by 2024 being "12x" and "4x" increases) — *confirmed* - **2024**: 99 WPV1 cases globally (74 Pakistan, 25 Afghanistan); geographic spread to new provinces — *confirmed* [WHO/Wikipedia] - **2025**: 51 WPV1 cases (31 Pakistan, 21 Afghanistan); environmental positives remain high; WPV1 detected in German wastewater — *confirmed* [Wikipedia/WHO Nov 2025] - **2025 (date unknown)**: GPEI extends timeline for WPV1 eradication certification beyond 2027 — *confirmed* [polioeradication.org] - **2025**: GPEI funding cuts flagged as acute threat — *confirmed* [WHO IHR EC] - **2026-05**: Multiple new cases in Pakistan and Afghanistan reported; attacks on health workers; WPV1 in Perth wastewater — *confirmed* [GDELT/khaama/prokerala] - **2026-06**: Afghanistan 2026 total rises to 6 cases — *confirmed* [khaama.com] - **2026-07**: Russia warns of worsening humanitarian crisis, rising Afghanistan cases — *reported* [khaama.com] --- # Event Will any calendar year 2024–2029 record zero reported wild poliovirus type 1 (WPV1) cases globally? # Outcomes to forecast - **Yes**: At least one year in 2024–2029 has zero WPV1 cases - **No**: Every year 2024–2029 has ≥1 WPV1 case # Kalshi market anchor **Current YES price: 10.0%** | 7-day change: +4.1% | 30-day change: -0.4% | Range (43d): 4.3%–10.7% | Avg daily volume: 270 contracts. Consensus leans heavily toward **No**. # Sub-question answers 1. **WPV1 cases in 2023 and 2024?** — 2023: ~12 cases (implied baseline); 2024: **99 cases** (74 Pakistan, 25 Afghanistan) — a 4–12x increase. [Wikipedia/WHO] 2. **Recent trend in Pakistan and Afghanistan?** — Sharply upward in 2024 (+12x Pakistan, +4x Afghanistan); moderated in 2025 (51 cases), but environmental surveillance still shows hundreds of positive samples. 2026 is tracking upward in Afghanistan with 6+ cases by June. [WHO IHR EC, khaama, Wikipedia] 3. **GPEI projected timeline?** — Original target was WPV1 interruption by 2027, certification by 2030. GPEI has formally extended this timeline, citing persistent transmission, funding gaps, and political will deficits. [polioeradication.org, WHO] 4. **Recent setbacks?** — Yes, multiple: 2024 case surge; GPEI funding cuts in 2025; attacks on vaccinators in Pakistan; cross-border migration compounding spread; WPV1 detected in wastewater in Germany (2025) and Australia (2026). [WHO IHR EC, GDELT] # Key facts (high-confidence, factual) 1. [Wikipedia] Only Pakistan and Afghanistan remain WPV1-endemic; all other WPV types eradicated. 2. [WHO] 99 WPV1 cases in 2024 — highest in recent years; 51 in 2025. 3. [GDELT/khaama] 2026 already has documented WPV1 cases in both countries as of July 2026. 4. [polioeradication.org] GPEI certification requires 3 consecutive zero-case years + reliable surveillance. 5. [WHO IHR EC] GPEI funding cuts in 2025 are an acute, unresolved risk factor. 6. [WHO] Geographic spread to new provinces/districts observed in 2024–2025. # Cross-market signals - **Kalshi related**: Only KXPOLIOELIM-30 exists; no ladder/bracket markets found. - **Polymarket**: No active polio markets found. - **Sportsbook**: N/A. # Analyst opinions and speculation - WHO IHR Emergency Committee (Nov 2025): "stands at a crossroads," new approaches needed; previous deadlines repeatedly missed. [WHO] - Academic review (NCBI): Impediments include political will loss, routine immunization gaps, repeated missed deadlines 2014–2024. [PMC12568124] - GPEI formally acknowledges timeline extension is necessary. [polioeradication.org] # Directional lean per outcome - **Yes (zero cases in any year 2024–2029)**: - *Supporting*: 2025 showed ~48% drop from 2024; if trajectory continued, could approach zero by 2027–2028. - *Opposing*: 2026 already has confirmed cases; environmental surveillance still widely positive; funding cuts threaten campaign quality; 4 of 6 remaining years already used up (2024, 2025, 2026 all non-zero); only 2027–2029 remain. - **No (every year has ≥1 case)**: - *Supporting*: Strong — active cases in all years to date; structural barriers (security, funding, cross-border movement) entrenched; GPEI itself extended timeline; zero cases by 2027 would require unprecedented acceleration. # Gaps / unknowns - Full 2026 case count not yet known (mid-year only). - Whether GPEI funding gaps will be resolved in 2026–2027. - Taliban cooperation in Afghanistan remains unpredictable. - Whether new vaccination strategies can rapidly close gaps. # Calibration anchors - **Kalshi current YES price: 10%** (primary anchor) - 2024 had 99 cases; 2025 had 51; 2026 trending upward again — zero before 2030 requires complete elimination within ~3 remaining years (2027–2029). - Historical precedent: Nigeria (last endemic outside Pak/Afg) took years to go from declining to zero; GPEI has missed every major deadline since 2000. - The 10% market price appears well-calibrated given structural evidence; recent +4.1% 7-day move may reflect 2025's lower case count, but 2026 reversal tempers optimism.

1. Both forecasters treat the 2025 decline (99→51 cases) as modest positive evidence but neither quantifies what trajectory would be needed: going from 51 cases in 2025 to zero by 2027 would require a faster absolute drop than any recent period, and 2026 is already trending upward (6 Afghanistan cases by June alone), making the 2025 improvement less meaningful than presented. 2. Neither forecaster explicitly weights the "three independent years must each hit zero" structure: the probability of zero in any single year must be raised to address that Yes requires at least one of three remaining years (2027, 2028, 2029) to hit zero, which is ~1-(1-p)³ compounding — if p per year is ~3-4%, the cumulative Yes is roughly 9-11%, consistent with Kalshi, but neither forecaster shows this decomposition or stress-tests whether their single-year implied probability is coherent. 3. Both forecasters under-weight the funding crisis as a near-term structural shock: the brief confirms GPEI funding cuts in 2025 are "acute and unresolved," which specifically threatens 2026-2027 campaign quality — the precise window when a trajectory reversal would need to begin for zero cases to be possible by 2027-2029. 4. Neither forecaster considers the Afghanistan-specific tail risk: Taliban cooperation is explicitly flagged as "unpredictable," and Afghanistan already has 6+ cases by June 2026 with Russia warning of a worsening humanitarian crisis — a scenario where Afghanistan becomes inaccessible could push Yes probability well below 8-9%, a downside tail neither forecaster prices. 5. Both forecasters anchor closely on Kalshi's 10% without critically examining whether the recent +4.1% 7-day move (noted in the brief) reflects genuine new information or noise — the brief itself suggests the 2026 upward reversal "tempers optimism," meaning the current 10% price may itself be slightly elevated, and forecasters should have considered going lower rather than clustering just below it.

7% (medium confidence)

Yes: 7% No: 93%

Only 2027-2029 remain, and each would need to hit zero from a nonzero baseline (51 in 2025, upward in 2026). Structural barriers—funding cuts, security, Taliban unpredictability—make rapid interruption unlikely. The critique correctly notes downside tail risks and that the recent +4.1% move may be noise, justifying a position slightly below the 10% Kalshi anchor, aligned with both forecasters.

Total pipeline time: 155.7s